Roger Longman @RealEndptsRog
Chairman Real Endpoints; former managing director and co-founder of Windhover Information realendpoints.com Joined April 2009-
Tweets43
-
Followers547
-
Following17
-
Likes8
Canaan’s Tim Shannon argues in BioCentury that solution for hi price of orphans is to lower marketing, development costs via innovative disintermediation. Disagree: cost of making/selling drugs largely unrelated to price. biocentury.com/biocentury/pro…
ABBV’s new-ish elagolix hardly a payer favorite – so why does Myovant think payers will react differently to relugolix? Biopharma R&D/investors need more objective understanding of value-to-payers.
People in MedAdantage cost less than trad Medicare? Not because of better MedAdvantage management, study says. kff.org/medicare/issue… My bet: more affluent people in MedAd – and richer folks healthier (because they can afford to take care better care?) & thus cost system less.
Fascinating proposal 10.1377/HBLOG20190405.396631 by @peterbachmd et.al. on price controls for post-patent biologicals. Alternative: pre-agreed biosim price from payer, without PA…enabling MD-directed substitution.
ESI excluding Lilly’s half-price Humalog in favor of rebated drug (& often higher cost share for diabetics) mostly about rebate guarantees to its clients. More troublesome structural incentives. biocentury.com/bc-extra/compa…
Looking forward to helping all of us thru the disruption!
Less $ESRX than employers, certain payers for whom volume+price is key equation. Eg, PCSK9s & Entresto, anyone? x.com/adverahealthjd…
@RealEndptsRog @JPZaragoza1 @AndyBiotech @steveusdin1 that is somewhat a unique situation with these 2 pcsk9
$ABBV's $350m PRV buy interesting in light of new @BioCentury piece "Overvaluing speed to market" by @RealEndptsRog biocentury.com/biotech-pharma…
Payers' wait-for-Repatha response to Praluent could impair value of market for priority-review vouchers.
Shrinking value of best/1st-in-class drugs. Higher ROI for payer-friendly followers. @RealEndptsRog in @INVIVOnow bit.ly/1IeRRR4
At #RESymp...elephant in living room of patient-centered oncology medical home is that docs get paid more for using more expensive drugs
RT: Sweetheart deal: Attend #RESymp, discuss #hc innovation for discounted $995. Code good all day: HAEB13. bit.ly/NVD2pM
If anyone doubts providers cracking down on hi-cost oncologics, see NYTimes piece by Sloan Kettering's Peter Bach and his talk at #RESymp.
E&Y's Bill Ferra on why fee-for-service is history & provider incentives that will work #RESymp and bit.ly/UM3cQ5
RT pleased to be able to announce E&Y as our official partner on the #RESymp for Nov 1-2. prn.to/PYgEbJ
RE Symposium looks 2b event of season (4 HC nerds) (check!)-congrats 2 @RealEndptsRog, @RealEndptsEllen 4 pulling this together.
Churn stops payers considering total cost of care & blunts arguments for Rx's. But churn becoming less important. bit.ly/SZS1w1
What do payers want from new drug? Usually can't/won't tell you. GSK has process for figuring it out. bit.ly/SU0w0F
Zeke Emanuel: $ prob of new tech, no comp data. DaVinci robot, prostate surgery: no randomized trials vs. alternatives. bit.ly/SUEpC6
Michael Gilman @michael_gilman
24K Followers 785 Following Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player, #immigrant. CEO @ArrakisTx. Just @gilman on...
Bruce Booth @LifeSciVC
50K Followers 731 Following Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
David Grainger @sciencescanner
14K Followers 797 Following Biotech entrepreneur & Partner @Medicxi Advocate of virtual, asset-centric R&D. All opinions my own
David Sable @dbsable
9K Followers 1K Following Life sciences, buy side. Ex ob/gyn and IVF doc. Roadie for @priyamayadas Adjunct at @columbia https://t.co/oHce7tNFsQ
Jeff Cranmer @jeff_cranmer
3K Followers 1K Following Executive Editor, @BioCentury. Jersey boy happily ensconced in Cali. Dad. Failed poet. Devoted Iggles fan. Cats. @Princeton, @SAISHopkins alum. Opinions? Mine.
Matthew Herper @matthewherper
111K Followers 3K Following Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Mastodon: @[email protected]
Jessica Merrill @Jessicaemerrill
3K Followers 346 Following biopharma reporter, writer, reader, vermonter, mom.
Simone Fishburn @FishburnSimone
3K Followers 1K Following Editor in Chief @BioCentury. Dr, the Ph.D-type. Biotech innovation & breaking barriers, one woman at a time. Views are mine, hope to make them yours too.
Peter Loftus @Loftus
21K Followers 2K Following Wall Street Journal @WSJ reporter - pharmaceuticals, medical devices, healthcare. [email protected]. Author of The Messenger
Ron Leuty @rleuty_biotech
11K Followers 2K Following #Biotech reporter @SFBusinessTimes; hardcore @Tigers fan; once rolled a 288. Tip me: [email protected], Signal or 415-722-2678. Also find me on Post.
Sarah Karlin-Smith @SarahKarlin
17K Followers 3K Following Covering intersection of pharma, policy & politics for @pharmapinksheet. @smpagwu adjunct Past @politico. Inflexible Yogi, Volunteer Clown. @amaxsmith fan.
John Maraganore 🇺�.. @JMaraganore
14K Followers 412 Following Founding CEO of @Alnylam. Pioneered RNAi therapeutics as a whole new class of medicines for patients. Now bioentrepreneur-at-large. Opinions are my own.
Jonathan Rockoff @jonathanrockoff
20K Followers 2K Following Deputy Coverage Chief, Health & Science and Health Business editor at the @WSJ. Email me at [email protected]
Ron Cohen Acorda CEO @DrRon81
3K Followers 930 Following Biotech entrepreneur, physician, erstwhile actor/singer. Passionate about advancing medical science and patient welfare.
Nature Reviews Drug D.. @NatRevDrugDisc
38K Followers 479 Following Editorial team of Nature Reviews Drug Discovery.
Stephen Hansen 🇺�.. @StephenPHansen
636 Followers 561 Following Husband. Father of 2 exhausting boys. Director of Biopharma Intelligence @BioCentury. Lives → U.K., roots in Minnesota. Opinions my own. Landscape photography⬇⬇
Russo Partners @russopartners
2K Followers 1K Following Public and Investor Relations for the Innovators in Healthcare and Technology
Peter B. Bach, MD @peterbachmd
14K Followers 1K Following Chief Med Officer @DELFIdiagnostic. Pulmonary & ICU doc. Tweets about health policy and grammar. Viewpoints my own.
Olivia Harris @atifmashfaq
10 Followers 197 Following We hold these truths to be self-evident, that all men are created equal, that they are endowed by their Creator with certain unalienable Rights, that among thes
Anna🧜🏻♀️ @GoodAnna1989
123 Followers 947 Following New energy wind investor who cares about nature and birds | Kind Ms. Anna 👱🏻♀️| Masters in Finance | Photography📷 | Cycling 🚲| Agree with DM 💌 yourself!
Yuna @cheezernegs
527 Followers 3K Following Art collection, 21st century new woman, love travel, adventure, believe in life, never back down
Elena albert @MADILIOUS
8 Followers 26 Following focus + discipline = results building dreams requires persistence,work everyday until you achieve them.
Bella Steve @SteveBella88
28 Followers 1K Following 丨Entrepreneur|Private Office丨Philanthropist|Digital Content丨
Renata Fransiska @hazle002
28 Followers 424 Following I like to listen to a piece of music in my spare time, or touch the fine paper with the tip of my pen and leave my memories on it
Ja @Jackie88Collier
266 Followers 3K Following
Donald Hawthorne @DBHawthorne
339 Followers 2K Following Helping companies uncover and solve for go-to-market blind spots. 12x C-suite (CEO-6, COO-2, CFO-4). Stanford MBA. Music. Sports. Free speech.
Antoine Barouky @Barouky1
289 Followers 2K Following biotech builder | Board Member | Global Executive
Philip Thompson @philipthompsono
21 Followers 91 Following I'm just a man with lesser talk but embrace more justify action
Lori Berninger @BerningerLori
18 Followers 202 Following Love Building Teams. Biotech. Pharma. Genomics
Celling Alpha @CellingAlpha
185 Followers 3K Following Tweets about biomedical sciences and finance. Ph.D., Not financial advice. Do your own research.
KS @Calvsams
180 Followers 1K Following
Delia @ReulandAnna
29 Followers 514 Following Hello everyone. I am Delia from Singapore. This is my twitter. Welcome everyone to follow me and become friends to exchange and learn from each other.
SpagayttiMonstr @SpagayttiMonstr
96 Followers 732 Following Homolibertarian, pronouns yippee/ki-yay, immigrant, healthcare. Horrified by the direction the gay community chose.
Yatagarasu @8atagarasu
134 Followers 1K Following
Erik Meredith @ErikMeredith
0 Followers 538 Following
Biopharma Mktr @harry_jose
235 Followers 2K Following Biotech B2B marketer; Occasional blogger; Quizzer; Trendspotter; Head of Marketing, Syngene, Infosys BPM; Personal views on topics of my interest
Sylvain Sachot @Sylvain_Sachot
140 Followers 359 Following
Matt Mealiffe @MattMealiffeMD
1K Followers 3K Following Dad, Medical Geneticist & biotech exec. Democracy fan. Free time: outdoors (esp. fishing, boating, kayak, snow sports), Stanford sports/Sharks/Warriors/Padres.
Alex Best @AlexBest1985
179 Followers 1K Following Director, Market Access Policy, Asia-Pacific. All views my own.
Sara Sandifer @sarasandifer
29 Followers 293 Following
Katie McCarthy @kgmccarthy
93 Followers 783 Following
Petrina Carcota @Petrina_Carcota
47 Followers 4K Following
carey goldberg @goldbergcarey
2K Followers 3K Following "The AI Revolution in Medicine: GPT-4 and Beyond" co-author, 2023; former Boston bureau chief for NYT, Bloomberg; longtime health/science reporter, WBUR, Globe
Karen Bergman @KarenBergman39
38 Followers 440 Following
Form Factor @Capital_55
9 Followers 5K Following
Lilyliu @burtyu4
389 Followers 3K Following Commit to small molecules' R&D, NCE, #drug impurities, #naturalproducts&fine chemicals. also produce bulk quantity of intermediates. ^^^https://t.co/qaWMWmDNqI
saul richmond @richmond_saul
15 Followers 350 Following
Molly @molly_scott_
1 Followers 140 Following
Berkowitz @Berkowij
68 Followers 633 Following
Nazo Ahmed @NazoAhmed
21 Followers 60 Following
TCurtice @TCurtice3
0 Followers 7 Following
Catherine J Arnold @FitpharmaInvest
80 Followers 807 Following interested in my kiddos, doggies, life science, fitness, investing, traveling the 🌎. grateful for a blessed life🙏
Anchor Molecular Inc @AnchorMolecular
113 Followers 1K Following Best-in-Class Reference Materials & Quality Controls for Liquid Biopsy Assays
emmanuella.lambert @emmanuellalamb2
1 Followers 77 Following
PQE Group ES @PQEGroupES
3K Followers 850 Following Dedicados a la calidad y excelencia desde 1998. Ofrecemos soporte extenso y comprensivo en todos los pasos del ciclo de vida de productos de Ciencias de la vida
Peter B. Bach, MD @peterbachmd
14K Followers 1K Following Chief Med Officer @DELFIdiagnostic. Pulmonary & ICU doc. Tweets about health policy and grammar. Viewpoints my own.
Sek Kathiresan MD @skathire
30K Followers 989 Following CEO @VerveTx $VERV; Imagine if a one-time treatment led to permanent lowering of LDL cholesterol: that’s what we are developing to treat heart attack
RealEndpoints @RealEndpoints
93 Followers 47 Following Real Endpoints, a health-care advisory/analytics firm delivering solutions that enhance appropriate access to innovation. https://t.co/50bRL3Vi56
David Frum @davidfrum
1.0M Followers 1K Following Read more at https://t.co/ncUQxYcjF4 and at https://t.co/k8AaBWWopx.
Indivisible CT-4 @indivisiblect4
412 Followers 368 Following Representing the 4th Congressional District, ICT4 joins with local and national groups to stand up against the Trump agenda. We are here and we will be heard!
Richard Pasternak @RCPasternak
50 Followers 44 Following
Amitabh Chandra @amitabhchandra2
19K Followers 622 Following Economist and Professor at HBS and HKS @Harvard. Tweets about food, dogs, piano, affogatos, India, and occasionally, health care.
Andy Biotech @AndyBiotech
78K Followers 746 Following #Biotech Investor | Recovering Scientist | May have L/S position in names mentioned | Opinions are strictly my own and not intended as investment advice
Melanie Senior @RealEndptsMel
768 Followers 63 Following Biopharma writer (Nature Bio, IN VIVO, EY Life Sci.); runner & twitter schizo
David Shaywitz @DShaywitz
15K Followers 37 Following MD, PhD. Not good at staying in swim lane. VP-Distinguished R&D Fellow in Data & Digital, Takeda. Also: @HarvardDBMI; @AEI Opinions my own.
Ellen Licking @EllenLicking
3K Followers 745 Following Recovering scientist/journalist. Parent of teens. "Attention is the beginning of devotion" - Mary Oliver
Ian Spatz @rockcreekpolicy
1K Followers 114 Following Health care policy nerd; faculty @USCPrice, Snr. Advisor @ManattHealth, principal rockcreekpolicy. Health care is 2 words. Mastodon: @[email protected]
ed silverman @edsilverman
6K Followers 155 Following Pharmalot columnist and senior writer at @STATnews.. former WSJer.. proud dad; likes music, dogs and taking naps
Chris Morrison @CT_Morrison
7K Followers 954 Following Personal account. ctm212 @ gmail https://t.co/xrRfJZ6a0D
Michael McCaughan @RPMReportMike
2K Followers 207 Following Founding Member, Prevision Policy LLC Business Implications of FDA and CMS Policy; Policy Implications of Biopharma Business
Mace: There are Democrats who trust Jordan Tapper: Jim Jordan? Mace: Yes Tapper: From Ohio? Mace: Yes Tapper: Name one
On the 11th attempt 😅 2020 Roland-Garros champ 🇵🇱 @iga_swiatek sets up a first-ever meeting with 2019 RG winner Barty 👀 #MMOPEN
Today is #NationalDoctorsDay. We at Real Endpoints are grateful for their courage in fighting this pandemic & their relentless focus on patients. Take a moment to show your gratitude for the #heroesofhealthcare. Link: bit.ly/2WUpzrf
@edyong209 No one is pointing out that this policy will LOSE the government money because stipends will be increased in grants to compensate, and those stipends will get charged overhead (50%+), meaning this tax increase just makes research much more expensive.
Mulvaney: No evidence that after-school programs to help kids get fed improves performance.
Chris Wallace to Reince Priebus: "Barack Obama whined about Fox News... but I gotta say, he never said we were an enemy of the people." #FNS
The drugs to watch in 2016 from @thomsonreuters. Annual 2020 revs >$1 billion.
Trends for United States
You might like
